Navigation Links
Oxylite

ProductsOxylite
Company Oxford Optronix Ltd.
Item Oxylite
Features Zero oxygen consumption, real-time monitoring, multi-parameter monitoring, MRI compatible, pre-calibrated probes, integrated temperature compensation.
Description The development of OxyLite represents a major breakthrough in the monitoring and assessment of tissue oxygen levels. Based on the principle of oxygen quenching of fluorescence, Oxylite is used for continuous quantitative monitoring of regional pO2 in tissue and fluids. This novel optical device has been shown to overcome many of the practical limitations of conventional polarographic oxygen sensors. Its optical nature also means it is suitable for use during MRI and other electro-magnetic environments.
Info Oxford Optronix Ltd.
Customer Service: +44 1235 821 803
Web site: http://www.oxford-optronix.com

Related medicine products :

1. Budde Halo Brain Retractor
2. Manman Self Retaining Brain Retractor
3. Sonomed-315 Ultrasound Brain A-Scanner
4. BrainSUITE® iMRI
5. Brain Type Natriuretic Peptide
6. NT proBrain Natriuretic Peptide
7. proBrainNatriuretic Peptide, NT
8. Straight Tissue Forceps
9. Bishop-Harmon Straight Tissue Forceps
10. Bishop-Harmon Curved Tissue Forceps
11. Straight Tissue Forceps - Non-Magnetic
TAG: Oxylite
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products:
(Date:11/22/2008)... Open enrollment is now ha... cover expenses not covered by Medicare, and may a...ny consumers are now shopping online for instant q... Fort Collins, CO (PRWEB) November 21, 2008 -- Med...nt for Medicare Supplement plans . Medicare Adva...
(Date:11/21/2008)...RANGE COUNTY, Calif., Nov. 21 Albu...keting firm, launches a new program offering big b...e have taken the large, expensive ad agency proces...ses with a very hands-on approach," says Matt Park...in 2002, combines experience and proven brand-buil...
(Date:11/21/2008)...ids, parents and schools need to work together to ...RIDAY, Nov. 21 (HealthDay News) -- Behavior that w...gnized as bullying. , And as mounting research ...he victim, mental-health professionals, schools, p... new ways to combat this threatening behavior. ,...
(Date:11/21/2008)..., TALLAHASSEE, Fla. -- A Florida State University... Wang has discovered an important new layer of reg...ad to a greater understanding of the way cancer be...al sciences at the College of Medicine, said the f...se cancer and could lead to the design of new drug...
Breaking Medicine News(10 mins):Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3
...he Hartford Financial Services Group Inc. has anno...ccessible to patients with prostate cancer//. This...re pretty high owing to better chemotherapy as wel...e company will introduce plans at standard rates "...
...ndia under the Revised National TB Control Program...g standardized//, good quality treatment and diagn... known that about 50 - 60 % of HIV-positive people...e the Union Health and Family Welfare Minister Anb...
...he detox diet and products had captured the market...t is under medical scrutiny. // A number of detox...vernment. This follows a report by the BBC which d...their medical claims. The Medical Health Care Pro...
... new study has found that attempting of suicide is...essful conditions. // Researchers from the Univer...tions in Canada and Britain studied approximately ...d at sawmills in British Columbia - and their chil...
Other Medicine News:Health News:India to Implement National Action Plan against TB-HIV 2
(Date:11/19/2008)... N.Y., Nov. 19 Biotech scientists ... toxicology research to better understand the effe... systems, reports Genetic Engineering & Biote...sted in figuring out a new compound,s mechanism of...icology technique, according to the November 15 is...
(Date:11/18/2008)...ristmasseals.org to learn more, make a donation o...TON, Nov. 17 Millions w..., courtesy of the American Lung Association. These...undraising tradition dating back to 1907 when the ...is. , , "Most Americans alive today have ...
(Date:11/18/2008)...udy will enroll newly diagnosed, elderly AML patie...e/ -- Celator Pharmaceuticals today announced that...d Phase 2 clinical study of CPX-351 (Cytarabine:Da...wly diagnosed acute myeloid leukemia (AML). , ...n, MD at the Weill Medical College of Cornell Uni...
(Date:11/12/2008)... Nov. 12 A new study be...ell will help answer the,question, what causes Par...ions in the medical research into,Parkinson,s dise...n to die,in the first place. Answering this questi... two nearly identical types of brain cells that pr...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3A Window Into Parkinson's Disease 2Kissing cousins 559 1Kissing cousins 559 2With the Largest Ever Buyout of a National Nursing Home Chain Pending New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursi 1996 1With the Largest Ever Buyout of a National Nursing Home Chain Pending New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursi 1996 2With the Largest Ever Buyout of a National Nursing Home Chain Pending New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursi 1996 3With the Largest Ever Buyout of a National Nursing Home Chain Pending New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursi 1996 4Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 1992 1Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 1992 2Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 1992 3Abbott Initiates Clinical Study to Evaluate Use of RX Herculink 28R 29 Elite 28TM 29 Renal Stent System for the Treatment of Renal Artery Stenosis 381 1Abbott Initiates Clinical Study to Evaluate Use of RX Herculink 28R 29 Elite 28TM 29 Renal Stent System for the Treatment of Renal Artery Stenosis 381 2Abbott Initiates Clinical Study to Evaluate Use of RX Herculink 28R 29 Elite 28TM 29 Renal Stent System for the Treatment of Renal Artery Stenosis 381 3
...7 - AVI BioPharma, Inc.,(Nasdaq:AVII) announced to...rget patient enrollment and released six-month,fol...s Appraisal.,The trial, currently being held in Ge...gene(R) antisense drug Resten-MP(TM), when,used in...e metal,stents, in the prevention of cardiovascula...
...cebo Adjusted Weight,Loss; Obesity Program to be D...irstCall/ -- Manhattan,Pharmaceuticals, Inc. today...linical trials of oral Oleoyl-estrone (OE). The re...ntrolled studies, one,in common obesity and the ot...ly or clinically meaningful placebo adjusted weigh...
Other Medicine Technology:AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4